Characterisation of the spectrum of demyelinating disease in Western Australia.
about
Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysisTreatment of neuromyelitis optica: state-of-the-art and emerging therapiesA population-based study of neuromyelitis optica in Caucasians.Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional StudyNeuromyelitis optica: an antibody-mediated disorder of the central nervous system.Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience.Spinal cord lesions and disability in Hispanics with multiple sclerosis.EFNS guidelines on diagnosis and management of neuromyelitis optica.Neuromyelitis optica (NMO)--an autoimmune disease of the central nervous system (CNS).Clinical characteristics and outcome of multiple sclerosis in Korea: does multiple sclerosis in Korea really differ from that in the Caucasian populations?What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease.The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.Clinical characteristics and outcomes of patients with Guillain-Barré and acquired CNS demyelinating overlap syndrome: a cohort study based on a literature review.Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.Epidemiology of neuromyelitis optica in Latin AmericaTumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients.Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
P2860
Q26861381-31409688-E5B9-47F1-A966-362EBAD24116Q28245749-4212F127-F980-4499-B0E8-AC29EAFBD1E2Q35719789-6A6F624B-6BD7-49C4-BD8F-37F885636718Q35722940-E4883666-3FD7-402E-BAB0-92CBA46E1090Q35738898-C1CCE023-FB93-431A-AAD3-57378AA7D4D5Q35785230-ACD0CC70-8CF5-448B-80C3-8AE888FA1519Q37275133-493BCF3C-8E58-4CAF-B0A9-AC6009F39578Q37763266-97C19284-4E90-458E-935A-51C7D588AD68Q37794273-7DB2A047-D967-46DB-82C7-E274F385E823Q38081357-5CA26374-ECE5-4FF7-B367-1FD8562510D3Q38088747-EA382C55-3B6A-44B3-B350-C19D88BFDBA6Q38130899-1A70EB5E-1795-4C3E-AAFD-54EB9439C37CQ38219081-08A815FF-FF73-4024-8D09-036ACD1EE363Q41533512-C9D99924-A377-4F25-87FD-20DEACAD5B45Q41985689-5CED5698-F9B3-40AE-9850-A95900566EDEQ42136634-4ED4D908-1B89-4F29-9539-B9AEBE8B047AQ48333927-5DDC5245-B384-4ACE-889C-2E1BA0554141Q51579145-E2F4AD99-7BBB-44CA-8874-B38F027E7B75
P2860
Characterisation of the spectrum of demyelinating disease in Western Australia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Characterisation of the spectrum of demyelinating disease in Western Australia.
@en
Characterisation of the spectrum of demyelinating disease in Western Australia.
@nl
type
label
Characterisation of the spectrum of demyelinating disease in Western Australia.
@en
Characterisation of the spectrum of demyelinating disease in Western Australia.
@nl
prefLabel
Characterisation of the spectrum of demyelinating disease in Western Australia.
@en
Characterisation of the spectrum of demyelinating disease in Western Australia.
@nl
P2093
P356
P1476
Characterisation of the spectrum of demyelinating disease in Western Australia
@en
P2093
P304
P356
10.1136/JNNP.2007.131177
P407
P577
2008-03-20T00:00:00Z